Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:PTX
Date3/2010
Raised
Post IPO Valuation

General Information

Websitepernixtx.com
CategoryBioTech
Phone800-793-2145
Employees
Founded1997

Offices

The Woodlands, USA
10003 Woodloch Forest Drive
The Woodlands, TX, 77380
USA

People

CEO, Chairman & Board of Directors
Vice President of Corporate Development
Board Member
Board Director
director
Chief Strategic Officer

Funding

TOTAL $34M
POST IPO FUNDING TOTAL $34M
Post IPO Equity, 1/2013
$34M
DEBT TOTAL $65M
Post IPO Debt, 2/2014
$65M

Tags

Pernix Therapeutics

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market. The Company’s pediatric products, designed to improve the health and well-being of children, are focused in the specific areas of allergy, upper respiratory, including nasal, chest congestion and cough, antibiotics and dermatology, including head lice, and contact dermatitis. The Company promotes its products through a sales and marketing organization with approximately 55 sales representatives, primarily in highly populated states, targeting pediatric and high-prescribing physicians that are in the top decile of physicians that prescribe its products. The Company’s current operating plan focuses on maximizing sales of its existing product portfolio. In addition, Pernix plans to accelerate growth by launching new products, line extensions, and new formulations and by acquiring and licensing approved products.

Recent Milestones

Videos

Screenshots

Pernix Therapeutics screenshot
Above: Home Page
Uploaded: 6/27/13

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. Pernix Attracts $65 Million Institutional Investment; Appoints Doug Drysdale as CEO; Settles Pending Legal Liabilities (fiercepharma.com) [edit]
Edit This Page
Last Edited 2/24/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy